Skip to content

IDRO

Active Private limited companyfounded 2020active for 6 yearsRuggeveldlaan 750, 2100 AntwerpKBO/BCE: BE 0748.378.754 subsidiary of Kinetic Analysis Group B.V.

Lifetime

5 annual accounts with figures on one time axis
peak €146,221 (2022)
€1,874▲ €56,781
lowest -€222,953 (2024)
-€150,536▲ €72,417
peak €58,491 (2023)
-€309,664▼ €150,536
€544,064▼ 25.6%
peak 2.5 FTE (2025)
2.5 FTE▲ 8.7%
Board1 name since 2020
1 directorKinetic Analysis B.V.
Owners6 names in the annual accounts
Documentsfilings and deeds
06-07-202625 days before the deadline
2025abbreviated format
Gross margin from -€54,908 to €1,874Loss of €150,536Staff from 2.3 FTE to 2.5 FTEEquity from -€159,129 to -€309,664Debts from €730,820 to €544,064Cash from €459,614 to €132,488

Key points

from the 2025 annual accounts

Equity

-€309,664
20212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€373,489 in two years
-222,9532024-150,5362025

The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.

Turnover

≈ €13,000 estimated

The abbreviated format states no turnover.

Debts

€544,064 232% of the balance sheet
Suppliers 4%Taxes and wages 1%Other 96%

Of this, €44,223 falls due within a year.

Staff

3 employees on 31-12-2025
102023102024442025

In 2025, 4 people joined and 4 left.

Position in the sector

-132.1%

Lower solvency than 90% of companies in research and development. Sector median 45.5% · 271 companies.

Checked score

54
Fair
Financially stronger than 27% of micro companies in research and development (NACE 72)
Probability in this band: 1.5% to 4.2%

Negative equity caps the score at 59.

Bankruptcy probability within 12 months
1.5% Low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.8% 01-2025: 0.8%● unchanged vs 12-2024lowest value 02-2025: 0.8%● unchanged vs 01-2025lowest value 03-2025: 0.8%● unchanged vs 02-2025lowest value 04-2025: 0.9%▲ +0.1 percentage points vs 03-2025 05-2025: 1.0%▲ +0.1 percentage points vs 04-2025 06-2025: 1.0%● unchanged vs 05-2025 07-2025: 1.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.9%▼ -0.2 percentage points vs 07-2025 09-2025: 1.0%▲ +0.1 percentage points vs 08-2025 10-2025: 1.0%● unchanged vs 09-2025 11-2025: 1.0%● unchanged vs 10-2025 12-2025: 1.0%● unchanged vs 11-2025 01-2026: 0.9%▼ -0.1 percentage points vs 12-2025 02-2026: 1.0%▲ +0.1 percentage points vs 01-2026 03-2026: 0.9%▼ -0.1 percentage points vs 02-2026 04-2026: 0.9%● unchanged vs 03-2026 05-2026: 0.9%● unchanged vs 04-2026 06-2026: 0.9%● unchanged vs 05-2026 07-2026: 0.9%● unchanged vs 06-2026 08-2026: 1.1%▲ +0.2 percentage points vs 07-2026 09-2026: 1.5%▲ +0.4 percentage points vs 08-2026highest value 10-2026: 1.5%● unchanged vs 09-2026 11-2026: 1.5%● unchanged vs 10-2026

Financial strength
Weak

0=equity -132.1% of total assets
94=short-term debt 18.9% · cash 56.5%
0=return on assets -64.2%

Score breakdown

raises risk
Capped at 59: negative equity
Negative equity -€309,664
Loss of €150,536, the second in a row (financial year 2025)
lowers risk
Liquidity: current ratio 4.05, cash €132,488, halved
Sector: Scientific research and development (NACE 72)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 6% of them on solvency, 84% on liquidity, 10% on profitability and 8% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,008 companies had the same profile as IDRO has now. Each dot stands for 16 companies, two years later.

83.0%
were still trading
8.4%
stopped another way
7.9%
went bankrupt
  • Micro
  • 5 to 10 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.8% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of IDRO itself is lower: 1.5% within 12 months. It rests on far more data about IDRO than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,008 companies, not a prediction for IDRO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

No credit on open account

Liquidity is ample, with a current ratio of 4.05 (4.16 in 2024), above the usual 1.5. Short-term debt is 18.9% and cash 56.5% of total assets. However, equity is negative.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Negative equity -€309,664
NBB · annual accounts
raises risk · Loss of €150,536, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 4.05, cash €132,488, halved
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
2122232425
2021 to 2025 · latest year -€309,664
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
25 days early
2024
16 days early
2023
37 days early
2022
55 days early
2021
128 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 52 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

KA
Kinetic Analysis B.V.
Director, GIJSSEL Maarten Pieter Eduard, since 09-06-2020
and 2 other shareholdersBoard & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0748378754
Capital increase of €5,333 4 new shares · General meeting of 19-12-2024 · Gazette deed
Registered office moved from Brussels to Antwerpen-Deurne New registered office: Ruggeveldlaan 750 te 2100 Antwerpen-Deurne · Previous registered office: Waterloolaan 65 te 1000 Brussel · Board meeting of 18-12-2023 · Gazette deed
First establishment Ruggeveldlaan 750, Antwerp
All 13 events

Comparable companies

same main activity, similar in size and age
Company
IDRO Antwerp €0.2m €1,874 -132.1% 2.5
GRAND MEDICAL (EUROPE) Niel €0.1m -€79,756 -1057.7% 0.4
sil'innov Fleurus €0.5m -€87,325 -139.8% 1.3
C-Path Diepenbeek €0.6m €15,228 -46.2% 2.3
Nutrifocus Kapellen €0.2m -€16,787 62.5% -
EUROPHARMEDTECH Ganshoren €0.05m -€5,941 -52.4% 1.2
BIO INX Ghent €1.2m -€14,253 -22.1% 4

These companies have the same main activity as IDRO: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €55,000 and €1.2m, founded between 2016 and 2022.

Official details

Source: KBO
Status
Active since 09-06-2020Normal situation
Activity
Research and development on biotechnologyNACE 72101and 1 other
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2025
Establishment unit
2.314.555.4042100 Antwerp, since 16-03-2021
Financial year end
31 December
Peppol
Reachable since 05-03-2025
Company details

Annual accounts 2025

€234,400▼ 59.0%
Employeeson 31-12-2025
3=
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on IDRO

IDRO files the abbreviated format. That format states no turnover. The gross margin fell from €20,875 in 2021 to €1,874 in 2025.

Kinetic Analysis Group B.V. holds 59% of the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IDRO

What is the company number of IDRO?
The company number of IDRO is 0748.378.754. The VAT number is the same number with BE in front: BE 0748.378.754.
Where is IDRO based?
The registered office is at Ruggeveldlaan 750, 2100 Antwerp.Company details
What does IDRO do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of IDRO?
IDRO is a private limited company (BV).
When was IDRO founded?
IDRO was founded on 09-06-2020.
Is IDRO still active?
Yes, IDRO is an active enterprise in the KBO register.
How many employees does IDRO have?
IDRO had an average of 2.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does IDRO fall under?
In its 2025 annual accounts, IDRO states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of IDRO?
The turnover in financial year 2025 is ≈ €13,000. This figure is estimated from the gross margin of €1,874 and 2,728 comparable companies of the same size. It probably lies between €5,300 and €32,000. It is a rough estimate.
Is IDRO profitable?
In financial year 2025, IDRO made a loss of €150,536.
Where can I find the annual accounts of IDRO?
IDRO filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of IDRO due?
IDRO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.